These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12497780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P, Sheridan DJ, Zannad F, Dubourg O, Guéret P, Karpov Y, de Leeuw PW, Palma-Gamiz JL, Pessina A, Motz W, Degaute JP, Chastang C.
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regression of left ventricular hypertrophy: do antihypertensive classes differ?
    Sheridan DJ.
    J Hypertens Suppl; 2000 Jul; 18(3):S21-7. PubMed ID: 10952084
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
    Dahlöf B, Gosse P, Guéret P, Dubourg O, de Simone G, Schmieder R, Karpov Y, García-Puig J, Matos L, De Leeuw PW, Degaute JP, Magometschnigg D, PICXEL Investigators.
    J Hypertens; 2005 Nov; 23(11):2063-70. PubMed ID: 16208150
    [Abstract] [Full Text] [Related]

  • 9. Regression of left ventricular hypertrophy with echocardiography: some lessons from the LIVE study.
    Gosse P, Dubourg O, Gueret P.
    J Hypertens; 2003 Jan; 21(1):217-21. PubMed ID: 12544454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension.
    Gosse P, Guez D, Guéret P, Dubourg O, Beauchet A, de Cordoüe A, Barrandon S.
    J Hypertens; 1998 Apr; 16(4):531-5. PubMed ID: 9797199
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical role of Natrilix SR in the treatment of at-risk hypertensive patients.
    Ambrosioni E, Veronesi M.
    J Hypertens Suppl; 2003 Mar; 21(1):S13-7. PubMed ID: 12769162
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R.
    Clin Pharmacokinet; 1999 Mar; 37 Suppl 1():21-32. PubMed ID: 10491730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.